Literature DB >> 657717

Effect of smoking on caffeine clearance.

W D Parsons, A H Neims.   

Abstract

The elimination of caffeine from saliva was compared in groups of healthy smokers (n = 13) and nonsmokers (n = 13). Mean caffeine t1/2 in smokers (3.5 hr) was shorter than that in the nonsmokers (6.0 hr). The body clearance of caffeine in the smokers (155 +/- 16 ml . kg-1 . hr-1) was greater than that in the nonsmokers (94 +/- 18 ml . kg-1 . hr-1) (p less than 0.05). No significant difference was noted in the apparent volume of distribution in smokers (720 +/- 67 ml . kg-1) and nonsmokers (610 +/- 80 ml . kg-1). These differences probably reflect the induction of hepatic aryl hydrocarbon hydroxylase (AHH) activity in smokers. The increased clearance of caffeine by smokers may contribute to the higher consumption of coffee reported to occur in this group.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657717     DOI: 10.1002/cpt197824140

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  72 in total

Review 1.  The impact of caffeine on vasodilator stress perfusion studies.

Authors:  Andre C Lapeyre; Tauqir Y Goraya; Donald L Johnston; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

2.  Effects of moderate exercise on the pharmacokinetics of caffeine.

Authors:  K Collomp; F Anselme; M Audran; J P Gay; J L Chanal; C Prefaut
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

Authors:  M A Butler; M Iwasaki; F P Guengerich; F F Kadlubar
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Effect of cigarette smoke on pharmacokinetics of oral, intrarectal, or intravenous indomethacin in rats.

Authors:  T Yoshida; Y Gomita; R Oishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

5.  Separate and combined effects of the social drugs on psychomotor performance.

Authors:  J S Kerr; N Sherwood; I Hindmarch
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  The effects of caffeine on blood pressure and heart rate: A review.

Authors:  P J Green; R Kirby; J Suls
Journal:  Ann Behav Med       Date:  1996-09

Review 7.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

8.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

Authors:  U Fuhr; K Klittich; A H Staib
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

9.  Impaired elimination of caffeine in cirrhosis.

Authors:  P V Desmond; R V Patwardhan; R F Johnson; S Schenker
Journal:  Dig Dis Sci       Date:  1980-03       Impact factor: 3.199

10.  Maternal caffeine consumption and risk of congenital limb deficiencies.

Authors:  Lei Chen; Erin M Bell; Marilyn L Browne; Charlotte M Druschel; Paul A Romitti; Rebecca J Schmidt; Trudy L Burns; Roxana Moslehi; Richard S Olney
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.